Antioxidative Effect of Plantago Asiatica L. Extract

October 27, 2011 updated by: Oran Kwon, Ewha Womans University

Acute Effect of Plantago Asiatica L. Extract on Antioxidative Biomarkers in Subjects With Mild Hyperlipidemia: A Pilot Study

The purpose of this study is to evaluate the antioxidant effect of Plantago asiatica L. extract in subjects with mild hyperlipidemia.

Study Overview

Detailed Description

The purpose of this study is to evaluate an acute effect of Plantago asiatica L. extract consumption on antioxidative biomarkers in subjects with mild hyperlipidemia. Subjects will intake Plantago asiatica L. extract with a high fat meal for oxidative stress loading. Antioxidative biomarkers will be measured after single-dose administration of Plantago asiatica L. extract.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of
        • Ewha Womans University / Hanaro Medical Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults age over 30
  • BMI(Body mass index) between 25 and 33 kg/m2
  • Total cholesterol between 200mg/dL and 250mg/dL OR Triglyceride between 150mg/dL and 220mg/dL OR LDL-cholesterol between 130mg/dL and 165mg/dL

Exclusion Criteria:

  • Subject who has taken part in other clinical trials within 30 days of screening visit
  • Subject who has taken medicines, Chinese medicines and Health/Functional Foods which can affect antioxidative biomarkers within 30days of screening visit
  • Subject who is pregnant or breast feeding
  • Subject who lost body weight over 4kg within 30days of screening visit
  • Alcoholic
  • Smoker
  • Subject who takes excessive exercise (over 7hours/week)
  • Subject who has hypertension(≥140/90mmHg), diabetes(fasting blood glucose ≥126mg/dL), kidney disease, hepatic disease or hyperthyroidism within 2years
  • Subject who has an allergy to the ingredients of study product

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Placebo
Liquid (80g) without Plantago asiatica L. extract
EXPERIMENTAL: • Plantago asiatica L. extract 5g
Liquid (80g) containing Plantago asiatica L. extract 5g
EXPERIMENTAL: Plantago asiatica L. extract 10g
Liquid (80g) containing Plantago asiatica L. extract 10g
EXPERIMENTAL: Plantago asiatica L. extract 20g
Liquid (80g) containing Plantago asiatica L. extract 20g

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Comet assay after single-dose consumption of Plantago asiatica L. extract
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)

Secondary Outcome Measures

Outcome Measure
Time Frame
Plasma FRAP
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
Plasma MDA
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
Plasma FFA
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
Plasma ox-LDL
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
Plasma erythrocyte SOD
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
Plasma triglyceride
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (ACTUAL)

April 1, 2011

Study Completion (ACTUAL)

September 1, 2011

Study Registration Dates

First Submitted

January 18, 2011

First Submitted That Met QC Criteria

January 18, 2011

First Posted (ESTIMATE)

January 19, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

October 28, 2011

Last Update Submitted That Met QC Criteria

October 27, 2011

Last Verified

October 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • PLA_Biofood

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oxidative Stress

Clinical Trials on Plantago asiatica L. extract 5g

3
Subscribe